GRANTS

127 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Investigator Initiated Extended Clinical Trial (R01)

Sponsor: National Institute of Allergy and Infectious Diseases, National Institute on Aging, National Institute of General Medical Sciences

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: March 7, 2017; December 7, 2017; March 7, 2018; December 7, 2018; March 7, 2019; December 6, 2019, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Enhancing the Target and Biomarker Discovery Efforts of the AMP-AD and M2OVE-AD Consortia (R01)

Sponsor: National Institute on Aging

Award: The NIA intends to commit $5 million in FY 2017 to fund three to five awards. The number of awards is contingent upon NIH appropriations.

Due Date: February 3, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Leveraging Existing Cohort Studies to Clarify Risk and Protective Factors for Alzheimers Disease and Related Dementias (R01)

Sponsor: National Institute on Aging

Award: The NIA intends to fund an estimate of five to eight awards, corresponding to a total of $8 million for fiscal year 2017. Future year amounts will depend on annual appropriations.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Research Career Enhancement Award to Advance Therapy Development for Alzheimer's (K18)

Sponsor: National Institute on Aging

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Comparative Biology of Neurodegeneration (R21)

Sponsor: National Institute on Aging

Award: NIA intends to commit $2.2M in FY17 to fund up to 10 awards.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01)

Sponsor: National Institute on Aging

Award: NIA intends to commit $3 million in FY 2017 to fund two to four awards.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01)

Sponsor: National Institute on Aging

Award: NIA intends to commit $7.5 million in FY 2017 to fund five to 10 awards.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01)

Sponsor: National Institute on Aging

Award: NIA intends to commit up to $3 million (total costs) in FY 2017 to support up to seven awards. The number of awards is contingent upon NIH appropriations.

Due Date: February 10, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R21/R33)

Sponsor: National Institute on Aging

Award: NIA intends to commit $3.2 million in FY 2017 to fund four to six awards. The number of awards is contingent upon NIH appropriations.

Due Date: January 12, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R33)

Sponsor: National Institute on Aging

Award: NIA intends to commit $3.2 million in FY 2017 to fund four to six awards. The number of awards is contingent upon NIH appropriations.

Due Date: January 12, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Role of Age-Associated Metabolic Changes in Alzheimer's Disease (AD) (R01)

Sponsor: National Institute on Aging

Award: NIA intends to commit $2.7 million in FY 2017 to fund six to eight awards.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01)

Sponsor: National Institute on Aging

Award: NIA intends to commit up to $3 million (total costs) in FY 2017 to support up to seven awards. The number of awards is contingent upon NIH appropriations.

Due Date: February 10, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Current Filters

No filters selected

Filter By